Titre:
  • Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer
Auteur:Boyle, Frances; Moy, Beverly; Finkelstein, Dianne D.M.; Goss, Paul E; Smith, Ian I.E.; O'Shaughnessy, Joyce; Ejlertsen, Bent; Buzdar, Aman; Fumoleau, Pierre; Gradishar, William; Martin, Miguel; Piccart-Gebhart, Martine; Pritchard, Kathleen; Lindquist, Deborah; Amonkar, Mayur; Huang, Yingjie; Rappold, Erica; Williams, Lisa L.S.; Wang-Silvanto, Jing; Kaneko, Tomomi
Informations sur la publication:European journal of cancer, 51, 6, page (685-696)
Statut de publication:Publié, 2015
Sujet CREF:Cancérologie
Mots-clés:Adjuvant breast cancer
Chemotherapy (TEACH) trial
Early breast cancer
Evaluation After
Growth Factor Receptor (HER2)
Health related quality of life
HER2 positive
HRQOL
Human Epidermal
Lapatinib
Placebo
SF-36
Tykerb/Tyverb
Note générale:SCOPUS: cp.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2015.02.005
info:pii/S0959804915001689
info:scp/84925372286